Osimertinib
astrazeneca
['osimertinib']
updated adura study results #asco2023 confirm benefit from osimertinib for cns dfs 
Professor of Medicine and Neurology; Director-Neuro-Oncology Program; Director-Neuro-Oncology Fellowship Program, Mayo Clinic Arizona;